EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 1 February 2024

Tackling inequalities: how can Europe beat cancer everywhere?

Tackling inequalities: how can Europe beat cancer everywhere?
31 January 2024

The risk of developing and surviving cancer are shaped by where you live, according to a new report. The report, written by The Swedish Institute for Health Economics (IHE) and commissioned by the EFPIA Oncology Platform, finds deep inequalities in access to prevention and screening, biomarker testing and innovative treatments, and in quality of life for cancer survivors.

How can we close the #CancerCareGap?

Vaccines Europe and EFPIA advocate for a holistic, data centered approach in Europe's fight...
31 January 2024

40% of all cancers are preventable and vaccination is a proven preventive measure for both HPV and HBV Read more

European Health Data Space: key aspects to be considered in the trilogue discussions
31 January 2024

EFPIA calls the co-legislators to seize this opportunity to thoroughly examine aspects raised in this paper to provide... Read more

Events

Getting to the heart of the matter: improving cardiovascular health in Europe
20 February 2024 (Virtual event)

Join us to be at the forefront of shaping cardiovascular health management in the EU. Read more

Digitally-enabled healthcare: Is our ecosystem on track?
07 March 2024 (Brussels and online)

Organised by the EU Health Coalition. Read more

What we are reading

Resistance to lung cancer treatment examined by CANCER-ID
On 01 February 2024 (IHI)

The CANCER-ID project applied molecular techniques to investigate whether mutant cells were causing patients to reject... Read more

Labour Plan for £10 Billion Investment in UK Life Sciences
On 30 January 2024 (Bloomberg)

Britain has struggled to become a life sciences superpower. Labour Party promises to crack down on regulatory delays.

Why Language Matters in Digital Endpoint Development
On 11 January 2024 (Karger)

Read the newly published article on novel approaches to clinical trials, developed by EFPIA CREG's working group.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu